Price T Rowe Associates Inc. MD decreased its position in Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 8.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,790,828 shares of the company’s stock after selling 363,576 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 6.47% of Molina Healthcare worth $1,557,387,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in shares of Molina Healthcare in the 4th quarter worth about $275,143,000. Wellington Management Group LLP lifted its holdings in Molina Healthcare by 12.8% during the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after purchasing an additional 436,060 shares during the last quarter. Capital Research Global Investors lifted its holdings in Molina Healthcare by 5.4% during the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after purchasing an additional 123,894 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Molina Healthcare by 127.0% during the fourth quarter. The Manufacturers Life Insurance Company now owns 192,847 shares of the company’s stock valued at $69,678,000 after purchasing an additional 107,895 shares during the last quarter. Finally, Los Angeles Capital Management LLC lifted its holdings in Molina Healthcare by 69.5% during the first quarter. Los Angeles Capital Management LLC now owns 223,825 shares of the company’s stock valued at $91,954,000 after purchasing an additional 91,813 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Price Performance
Shares of MOH stock traded up $11.19 during trading on Friday, hitting $335.36. The company had a trading volume of 1,251,147 shares, compared to its average volume of 770,644. The company has a quick ratio of 1.49, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The stock’s 50-day moving average is $306.95 and its two-hundred day moving average is $353.35. The stock has a market capitalization of $19.65 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 1.05 and a beta of 0.58. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92.
Insider Buying and Selling at Molina Healthcare
In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the transaction, the director now directly owns 16,945 shares in the company, valued at $5,816,710.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the transaction, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO James Woys sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the transaction, the chief operating officer now owns 53,613 shares in the company, valued at approximately $18,504,526.95. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have commented on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a report on Wednesday, July 10th. TD Cowen dropped their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a report on Tuesday, July 23rd. Robert W. Baird assumed coverage on shares of Molina Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $405.00 price target on the stock. Finally, Jefferies Financial Group lowered their price target on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a report on Wednesday. One analyst has rated the stock with a sell rating, five have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $376.18.
Get Our Latest Stock Report on MOH
Molina Healthcare Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Do ETFs Pay Dividends? What You Need to Know
- Is Crypto Cool Again? What Stocks You Should Be Watching
- How to Evaluate a Stock Before Buying
- Why Call Options Volume for These 2 Stocks Spiked Together
- Where Do I Find 52-Week Highs and Lows?
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.